The present director Jan M. Van Ree , has the task of the objectives of the research included in the new institute. For this purpose, functional sections were formed, each a each a defined research topic, the use of resources and research output. The new momentum of the Institute is expressed among others in the modernized logo.

.. Pharmaceuticals Pharmaceuticals Reports Positive Results from Second Phase I study of GAL-021 for the treatment of respiratory depression This study confirms our earlier Phase I results and provides a clear dose – range for future studies, said James F. Galleon Senior Vice President, clinical Research and Development and Chief Medical Officer. We identified a maximum tolerated dose of the drug in healthy subjects hyperventilation hyperventilation and reduced CO2 emissions and is now with plans the impact of the effects of GAL-021 in patients with opioid-induced respiratory failure go.Is estimated from parents purposes only, children in the in the current study, averaged 13 cigarettes per day. Parental estimations common in research and a span of children tobacco smoke, but the current study went even step further and matters of parental estimates may not be accurate, Dr. Yolton said an Assistant Professor of Pediatrics at the University of Cincinnati College of Medicine in.

Young with asthma who are exposed tobacco smoke have higher levels of hyperactivity, aggression, depression and other behavioral disorders, according to to researchers at Cincinnati Children Hospital Medical Center.